CCT8 and B-cell non-Hodgkin lymphoma: Overexpression of CCT8 could promote the proliferation, accelerate the G1/S transition and reverse cell adhesion-mediated drug resistance (CAM-DR) phenotype in B-cell non-Hodgkin’s lymphoma (Yin et al., 2016).